
Sign up to save your podcasts
Or
The Covid-19 vaccine was developed at an unusually rapid pace, and now the public's expectations are high for what science can deliver. It's a good thing we're in a science moment. Gobs of data are being produced, researchers are collaborating more, and the public is engaged. But is the pace of discovery keeping up with the science? Alison Snyder, managing editor at Axios, interviews Darío Gil, senior vice president and director of IBM Research at IBM, Serpil Erzurum, chief research and academic officer of Cleveland Clinic, and Nicholas Dirks, president and CEO of the New York Academy of Sciences, about the pace of discovery in an age of streamlined research and development processes and advanced computing.
aspenideas.org
4.2
226226 ratings
The Covid-19 vaccine was developed at an unusually rapid pace, and now the public's expectations are high for what science can deliver. It's a good thing we're in a science moment. Gobs of data are being produced, researchers are collaborating more, and the public is engaged. But is the pace of discovery keeping up with the science? Alison Snyder, managing editor at Axios, interviews Darío Gil, senior vice president and director of IBM Research at IBM, Serpil Erzurum, chief research and academic officer of Cleveland Clinic, and Nicholas Dirks, president and CEO of the New York Academy of Sciences, about the pace of discovery in an age of streamlined research and development processes and advanced computing.
aspenideas.org
10,368 Listeners
38,203 Listeners
43,391 Listeners
6,649 Listeners
10,682 Listeners
12,532 Listeners
58 Listeners
111,352 Listeners
2,288 Listeners
29 Listeners
376 Listeners
6,755 Listeners
15,952 Listeners
3 Listeners
0 Listeners
5 Listeners
15,180 Listeners
64 Listeners
1,450 Listeners
417 Listeners